The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Iliuk R.D.

Sankt-Peterburgskiĭ nauchno-issledovatel'skiĭ psikhonevrologicheskiĭ institut im. V.M. Bekhtereva

Krupitskiĭ E.M.

Sankt-Peterburgskiĭ nauchno-issledovatel'skiĭ psikhonevrologicheskiĭ institut im. V.M. Bekhtereva

Torban M.N.

Sankt-Peterburgskiĭ nauchno-issledovatel'skiĭ psikhonevrologicheskiĭ institut im. V.M. Bekhtereva

Kozlov A.P.

Biomeditsinskiĭ tsentr, Sankt-Peterburg

Blinnikova K.N.

Shkola obshchestvennogo zdorov'ia Universiteta Alabama, 4. Ĭel'skiĭ universitet, Departament épidemiologii i obshchestvennogo zdorov'ia, SShA

Khaĭmer R.

Ĭel'skiĭ universitet, Departament épidemiologii i obshchestvennogo zdorov'ia, SShA

Grin T.

Ĭel'skiĭ universitet, Departament épidemiologii i obshchestvennogo zdorov'ia, SShA

Grau L.

Ĭel'skiĭ universitet, Departament épidemiologii i obshchestvennogo zdorov'ia, SShA

The study of characteristics of overdose among users of opioid drug injections

Authors:

Iliuk R.D., Krupitskiĭ E.M., Torban M.N., Kozlov A.P., Blinnikova K.N., Khaĭmer R., Grin T., Grau L.

More about the authors

Read: 4691 times


To cite this article:

Iliuk RD, Krupitskiĭ EM, Torban MN, et al. The study of characteristics of overdose among users of opioid drug injections. S.S. Korsakov Journal of Neurology and Psychiatry. 2010;110(5‑2):33‑43. (In Russ.)

References:

  1. Komitet po zdravookhraneniyu Pravitel'stva Sankt-Peterburga. Sovet po koordinatsii narkologicheskoi pomoshchi naseleniyu Sankt-Peterburga. Sostoyanie narkologicheskoi pomoshchi naseleniyu Sankt-Peterburga s analizom rasprostranennosti, dinamiki i tendentsii razvitiya narkologicheskoi zabolevaemosti v Sankt-Peterburge, po rezul'tatam raboty za period s 2000 po 2005 g. Informatsionnyi byulleten'. St-Peterburg 2006;32.
  2. Koshkina E.A. Rasprostranennost' narkomanii i toksikomanii v Rossii segodnya. Zhurn mikrobiol epidemiol i immunobiol 2000;4:15-19.
  3. Koshkina E.A., Kirzhanova V.V. Osobennosti rasprostranennosti narkologicheskikh rasstroistv v Rossiiskoi Federatsii v 2005 g. Psikhiat i psikhofarmakol 2007;1:9:19-22.
  4. Koshkina E.A. Doklad «Ezhegodnoe provedenie monitoringa masshtabov rasprostraneniya i nezakonnogo potrebleniya narkotikov». V kn.: Mezhdunarodnaya konferentsiya «Effektivnaya i dokazatel'naya narkologiya v epokhu VICh». M 2008.
  5. Krupitskii E.M., Burakov A.A., Romanova T.N. i dr. Sindrom angedonii u detoksitsirovannykh bol'nykh opiinoi narkomaniei: otsenka i lechenie. V kn.: Reabilitatsiya narkozavisimykh: novye reabilitatsionnye tekhnologii i meditsinskie aspekty. St-Peterburg: Reanar 1999;18.
  6. Melent'ev A.B., Novikov P.I. O roli alkogolya pri peredozirovke geroina. SME 2002;1:12-17.
  7. Pyatnitskaya I.N. Narkomanii. Rukovodstvo dlya vrachei. M: Meditsina 1994;544.
  8. Safronov A.G. Opioidnaya narkomaniya. St-Peterburg 1998;57.
  9. Sivolap Yu.P. K probleme psikhopatologii addiktivnykh rasstroistv. Zhurn nevrol i psikhiat 2007;107:11:4-6.
  10. Sivolap Yu.P., Savchenkov V.A. O printsipal'nykh vozmozhnostyakh neirolepticheskoi terapii v narkologii. Na puti k professional'noi narkologii (analiticheskie ocherki i stat'i). M: Media Press 2008;338-348.
  11. Tarabrina N.V. Praktikum po psikhologii postravmaticheskogo stressa. St-Peterburg: Piter 2001.
  12. Federal'naya sluzhba Rossiiskoi Federatsii po kontrolyu za oborotom narkotikov. [Elektronnyi resurs]. Informatsionnye soobshcheniya ot 27.06.06. Rezhim dostupa: http://fskn.gov.ru, svobodnyi.
  13. Al Ansari A.M., Hamaden R.R., Matar A.M. et al. Risk factors associated with overdose among Bahraini youth. Suicide life-threatening behavior 2001;31:197-206.
  14. Al-Jahali H., Al-Johant A., Al-Hakawi A. et al. Pattern and risk factors for intentional drug overdose in Saudi Arabia. Canad J Psychiat 2004;49:331-334.
  15. Coffin P.O., Ahern J., Dorris S. et al. More pharmacists in high-risk neighborhoods of New York City support selling syringes to injection drug users. J Am Pharmac Ass 2002;42:62-67.
  16. Darke S., Ross J., Hall W. Overdose among heroin users in Sydney, Australia. Part I. Prevalence and correlates of non-fatal overdose. Addiction 1996;91:405-411.
  17. Darke S., Ross J., Hall W. Overdose among heroin users in Sydney, Australia. Part II: Responses to overdose. Addiction 1996;91:413-417.
  18. Davidson P.J., Ochoa K.C., Hahn J.A. et al. Witnessing heroin-related overdoses: The experiences of young injectors in San Francisco. Addiction 2002;97:1511-1516.
  19. Derogatis L.R., Ricklers K., Rock A.F. The SCL-90 and the MMPI: A step in the validation of a new self-report scale. Br J Psychiat 1976;128:280-289.
  20. Derogatis L.R. SCL-90R administration, scoring and procedures manual. Baltimore 1977.
  21. Dorabjee J., Samson L. A multi-centre rapid assessment of injecting drug use in India. Int J Drug Policy 2000;11:99-112.
  22. Drew L.R.H. Avoidable deaths from drug intoxication. Med J Australia 1982;2:215.
  23. Eskild A., Magnus P., Samuelson S.O. et al. Differences in mortality rates and causes of death between HIV positive and HIV negative intravenous drug users. Int J Epidemiol 1993;22:315-320.
  24. Fathelrahman A.I., Rahman A.F., Zain Z.M., Tengku M.A. Factors associated with adult poisoning in northern Malaysia: A case-control study. Human Exp Toxicol 2006;25:167-173.
  25. Frischer M., Bloor M., Goldberg D. et al. Mortality among injecting drug users: a critical reappraisal. J Epidemiol and Comm Health 1993;47:59-63.
  26. Green T.C., Grau L.E., Heimer R., Kim M. Distinguishing signs of opioid overdose and indication for naloxone: An evaluation of naloxone training and distribution programs in the United States. In: 18th Annual International Conference on Drug-Related Harm. Warsaw (Poland) 2007.
  27. Kartikeyan S.K., Chatruvedi R.M., Bhalerao V.R. Role of the family in drug abuse. J Postgrad Med 1992;38:5-7.
  28. Kozlov A.P., Shaboltas A.V., Toussova O.V. et al. HIV incidence and factors associated with HIV acquisition among injection drug users in St. Petersburg, Russia. AIDS 2006;20:901-906.
  29. Krupitsky E.M., Zwartau E.E., Masalov D.V. et al. Naltrexone with or without fluoxetine for preventing relapse to heroin addiction in St. Petersburg, Russia. J Substance Abuse Treatment 2006;31:319-328.
  30. Kumar M.S., Mudaliar S., Thygarajan S.P. et al. Rapid assessment and response to injecting durg use in Madras, South India. Int J Drug Policy 2000;11:83-98.
  31. Manning F.J., Ingraham L.H., Derouin E.M. et al. Drug «overdoses» among U.S. soldiers in Europe, 1978-1979. Psychological autopsies following deaths and near-deaths. Int J Addict 1983;18:153-156.
  32. Mclellan A.T., Luborsky L., O’Brein C.P., Woody G.E. An improved diagnostic instrument for substance abuse patients, the Addition Severity Index. J Nervous and Mental Dis 1980;168:26-33.
  33. Mclellan A.T., Kushner H., Metzger D. et al. The fifth edition of the Addiction Severity Index. J Substance Abuse Treatment 1992;9:199-213.
  34. Moffet L.A., Radenhausen R.A.Assessing depression in substance abusers: Beck Depression Inventory and SCL-90R. Addictive Behaviors 1990;15:179-181.
  35. Mueser K.T., Bennett M., Kushner M.G. Epidemiology of substance use disorders among persons with chronic mental illness. In: Double jeopardy chronic mental illness and substance use disorders. Eds. A.F. Lehman, L.B. Dixon. Langhorne: Harwood Academic Publishers 1997;9-25.
  36. Oppenheimer E., Tobut C., Taylor C., Andrew T. Death and survival in a cohort of heroin addicts from London clinics: a 22 year follow-up. Addiction 1994;89:1299-1308.
  37. Orford J., Natera G., Copello A. et al. Coping with Alcohol and Drug Problems: The Experiences of Family Members in Three Contrasting Cultures. London: Routledge 2005.
  38. Perucci C.A., Davoli M., Rapiti E. et al. Mortality of intravenous drug users in Rome: a cohort study. Am J Public Health 1991;81:1307-1310.
  39. Pollini R.A., Mccall L., Mehta S.H. et al. Non-fatal overdose and subsequent drug treatement among injection drug users. Drug and Alcohol Depend 2006;83:104-110.
  40. Powis B., Strang J., Griffiths P. et al. Self-reported overdose among injecting drug users in London: extent and nature of the problem. London 1999.
  41. Sacks S., Sacks J.Y., De Leon G. et al. Modified therapeutic community for mentally ill chemical abusers-background. Influences, program description, preliminary findings. Substance Use and Misuse 1997;32:9:1217-1259.
  42. Schmitz N., Kruze J., Heckrath C., Alberti L.T. Diagnosing mental disorders in primary care: The General Health Questionnaire (GHQ) and the Symptom Checklist (SCL-90R) as screening instruments. Soc Psychiat Psychiat Epidemiol 1999;34:360-366.
  43. Sergeev B., Karpets A., Sarang A., Tikhonov M. Prevalence and circumstances of opiate overdose among injection drug users in the Russian Federation. J Urban Health 2003;80:212-219.
  44. Strang J., Mccabboni J., Best D. et al. Loss of tolerance and overdose mortality after impatient opiate detoxification: Follow up study. Br Med J 2003;326:959-960.
  45. Walsh R.A. Opioid drug accidental deaths in the Newcastle area of New South Wales, 1970-1987. Drug Alcohol Rev 2003;10:79-83.
  46. Wang C., Vlahov D., Galai N. et al. The effect of HIV infection on overdose mortality. AIDS 2005;19:935-942.
  47. Zador D., Sunjic S., Darke S. Heroin-related deaths in New South Wales, 1992: toxicological findings and circumstances. Med J Australia 1996;164:204-207.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.